Syntara Ltd
ASX:SNT

Watchlist Manager
Syntara Ltd Logo
Syntara Ltd
ASX:SNT
Watchlist
Price: 0.069 AUD 6.15% Market Closed
Market Cap: 112.1m AUD

Wall Street
Price Targets

SNT Price Targets Summary
Syntara Ltd

Wall Street analysts forecast SNT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNT is 0.189 AUD with a low forecast of 0.121 AUD and a high forecast of 0.263 AUD.

Lowest
Price Target
0.121 AUD
76% Upside
Average
Price Target
0.189 AUD
173% Upside
Highest
Price Target
0.263 AUD
280% Upside
Syntara Ltd Competitors:
Price Targets
SHILPAMED
Shilpa Medicare Ltd
9% Upside
185750
Chong Kun Dang Pharmaceutical Corp
46% Upside
016580
Whanin Pharm Co Ltd
36% Upside
JNJ
Johnson & Johnson
11% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
8% Upside
MANKIND
Mankind Pharma Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Syntara Ltd

For the last 8 years the compound annual growth rate for Syntara Ltd's revenue is -14%. The projected CAGR for the next 3 years is 9%.

-14%
Past Growth
9%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Syntara Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Syntara Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNT's stock price target?
Price Target
0.189 AUD

According to Wall Street analysts, the average 1-year price target for SNT is 0.189 AUD with a low forecast of 0.121 AUD and a high forecast of 0.263 AUD.

What is Syntara Ltd's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Syntara Ltd's revenue is -14%. The projected CAGR for the next 3 years is 9%.

Back to Top